These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Desloratadine: an update of its efficacy in the management of allergic disorders. Murdoch D; Goa KL; Keam SJ Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522 [TBL] [Abstract][Full Text] [Related]
6. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Ring J; Hein R; Gauger A; Bronsky E; Miller B Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962 [TBL] [Abstract][Full Text] [Related]
7. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy. DuBuske L Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. Agrawal DK Expert Opin Investig Drugs; 2001 Mar; 10(3):547-60. PubMed ID: 11424898 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Ortonne JP; Grob JJ; Auquier P; Dreyfus I Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis. Chervinsky P; Nayak A; Rooklin A; Danzig M Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574 [TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of desloratadine for the management of allergic disease. Berger WE Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713 [TBL] [Abstract][Full Text] [Related]
12. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Simpson K; Jarvis B Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Horak F; Stübner P; Zieglmeyer R; Harris AG Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447 [TBL] [Abstract][Full Text] [Related]
14. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
15. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. Crampton HJ Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545 [TBL] [Abstract][Full Text] [Related]
16. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]. Salmun LM; Lorber R BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial. Keith PK; Luciuk G Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463 [TBL] [Abstract][Full Text] [Related]
18. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Bachert C Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095 [TBL] [Abstract][Full Text] [Related]